Arthritis Research & Therapy

official impact factor 4.36

This article is part of the supplement: The Scientific Basis of Rheumatology

Engineering of tissue inhibitor of metalloproteinases mutants as potential therapeutics

Hideaki Nagase* and Keith Brew

Arthritis Res 2002, 4(Suppl 3):S51-S61 doi:10.1186/ar573


London, UK. 24-26 June 2002

Accesses  

  • Last 30 days: 61 accesses
  • Last 365 days: 575 accesses
  • All time: 8792 accesses

Cited by

BioMed Central: 2 citations